The Valley Desk

NCT02289209 · Interventional trial

Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck

Overall registry status Completed

Phase 2

Conditions Carcinoma, Squamous Cell of Head and Neck, Recurrent Head and Neck Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov